Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China Comment

被引:1
|
作者
Zhang, Peize [1 ,2 ]
Tan, Jie [1 ]
Lin, Yi [1 ]
Zhang, Hailin [1 ]
Deng, Guofang [1 ]
Chen, Xiaoyou [2 ]
机构
[1] Natl Clin Res Ctr Infect Dis, Peoples Hosp Shenzhen 3, Pulm Med & TB, 29 Bulan Rd, Shenzhen 518112, Peoples R China
[2] Beijing TB & Thorac Tumor Inst, 9 Beiguan St, Beijing 101149, Peoples R China
来源
DRUG DISCOVERIES AND THERAPEUTICS | 2022年 / 16卷 / 02期
关键词
Linezolid; MDR; XDR-TB; China; drug resistance; EFFICACY; SAFETY;
D O I
10.5582/ddt.2022.01024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Linezolid has been one of the key anti-tuberculosis agents for the treatment of multidrug-resistant tuberculosis (MDR-TB)/extensively drug-resistant tuberculosis (XDR-TB). It used to be very expensive and was not covered by social insurance from local governments. Nevertheless, a growing number of patients in China received linezolid in their anti-MDR/XDR TB regimens over the past decade. Many scholars in China have reported their experience using linezolid to treat patients with MDR/XDR-TB. In view of this, existing evidence of the efficacy and safety of linezolid and problems faced by Chinese patients with MDR/XDR-TB are summarized here.
引用
收藏
页码:96 / 98
页数:3
相关论文
共 50 条
  • [1] Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
    Seung, Kwonjune J.
    Keshavjee, Salmaan
    Rich, Michael L.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (09):
  • [2] Multidrug-resistant and extensively drug-resistant tuberculosis
    Chiang, C-Y.
    Yew, W. W.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (03) : 304 - 311
  • [3] Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
    Tabarsi, Payam
    Yadegarinia, Davood
    [J]. ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (01):
  • [4] Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China
    Zhang, Zhijian
    Pang, Yu
    Wang, Yufeng
    Liu, Changting
    Zhao, Yanlin
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (03) : 231 - 235
  • [5] TREATMENT OF MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS IN ADOLESCENT PATIENTS
    Rodrigues, Magda
    Brito, Maria
    Villar, Miguel
    Correia, Paula
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : 657 - 659
  • [6] Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
    Jan-Willem C. Alffenaar
    Richard van Altena
    Ilse M. Harmelink
    Patricia Filguera
    Esther Molenaar
    A. Mireille A. Wessels
    Dick van Soolingen
    Jos G. W. Kosterink
    Donald R. A. Uges
    Tjip S. van der Werf
    [J]. Clinical Pharmacokinetics, 2010, 49 : 559 - 565
  • [7] Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
    Sotgiu, Giovanni
    Lange, Christoph
    Richardson, Morgan D'Arcy
    Matteelli, Alberto
    Centis, Rosella
    Eker, Barbara
    Guenther, Gunar
    Spanevello, Antonio
    Migliori, Giovanni Battista
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (04) : 879 - 883
  • [8] Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
    Alffenaar, Jan-Willem C.
    van Altena, Richard
    Harmelink, Ilse M.
    Filguera, Patricia
    Molenaar, Esther
    Wessels, A. Mireille A.
    van Soolingen, Dick
    Kosterink, Jos G. W.
    Uges, Donald R. A.
    van der Werf, Tjip S.
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (08) : 559 - 565
  • [9] Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
    Gandhi, Neel R.
    Nunn, Paul
    Dheda, Keertan
    Schaaf, H. Simon
    Zignol, Matteo
    van Soolingen, Dick
    Jensen, Paul
    Bayona, Jaime
    [J]. LANCET, 2010, 375 (9728): : 1830 - 1843
  • [10] Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis
    Blondal, K.
    Viiklepp, P.
    Guomundsson, L. J.
    Altraja, A.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (09) : 1228 - 1233